Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
Donna Cryer advocates for many liver-related conditions as founder and CEO of the Global Liver Institute.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
The application is based on study results showing that up to 23% of treated patients saw an improvement in liver fibrosis.
Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
A placebo-controlled study of obeticholic acid showed it improved liver fibrosis with no worsening of non-alcoholic steatohepatitis.
Las Vegas resident Stella Armstrong cured her hep C and the joy-killing fatigue and pain that came with it.
The placebo-controlled trial Phase III trial of selonsertib had sought to improve fibrosis while not worsening NASH.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.